USPTO serial 99748811
CODABLE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- DUBOIS, SUSAN L
- Law office
- TMO LAW OFFICE 111
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with CODABLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Milton Bridge, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexandra MacKay
Alexandra MacKay Stites & Harbison PLLC401 Commerce StreetSuite 800Nashville, TN 37219Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Machine learning software; machine learning software for analysis; software for predicting protein expression; computer software platforms; software relating to medical research; algorithms, being computer software; downloadable computer software programs; computer applications in the fields of recombinant protein production, genetic engineering, immunology, cell engineering, biopharmaceuticals, biotechnology, molecular biology, modulating therapeutics, assay systems and antigens; software in the field of culture methods for microbes, bacteria, yeast, fungi and mammalian cells; software in the fields of genomes, genetic mapping, molecular genetics, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, biochemical reagents and biochemical assays; downloadable software, namely, lab information management systems; downloadable software for remote diagnostics; software used to analyse and determine codon usage; data processing software; downloadable computer software for scientific analysis of genetic sequences | ACTIVE | — |
| 042 | Design and development of software; design of algorithms; analysis, management and review of technical data; genetic engineering services; research relating to genetics; software engineering; design, development and maintenance of software in the fields of recombinant protein production, genetic engineering, immunology, cell engineering, biopharmaceuticals, biotechnology, molecular biology, modulating therapeutics, assay systems and antigens; providing non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; providing non-downloadable software for monitoring patient health; development of machine learning software; software as a service [Saas] featuring software for machine learning; development and testing of computing methods, algorithms and software; design and development of software in the field of culture methods for microbes, bacteria, yeast, fungi and mammalian cells; design, development and maintenance of software in the fields of genomes, genetic mapping, molecular genetics, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, biochemical reagents and biochemical assays; contract research services relating to molecular sciences; research services in the field of proteins, antibodies, microorganisms and cells; research and development services; biological, biomedical and pharmacological research, analysis and development services; research and development of biological drug delivery platforms; laboratory services; culturing of cells for scientific or medical research purposes; testing of human tissues and stem cells for scientific or medical research purposes; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes; cell programming services; scientific services relating to the isolation and cultivation of human tissues and cells; cell separation services; development of testing methods; diagnostic and testing services; preparation of reports in the field of biotechnology; technical testing, measuring, survey and evaluation services; design and development of scientific cell culture, cell therapy or gene therapy equipment and apparatus; consultancy, information and advisory services relating to all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 7, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 7, 2026 | NWAP | NEW APPLICATION ENTERED | — |